Related Experiment Video
Updated: Sep 14, 2026

Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
Published on: September 22, 2020
Coronary and circulatory support strategies for percutaneous transluminal coronary angioplasty in high-risk patients
1Department of Medicine, Queen Mary Hospital, University of Hong Kong.
Insights
Percutaneous Transluminal Coronary Angioplasty (PTCA) is increasingly used for complex heart conditions. Various circulatory support devices enhance safety for high-risk angioplasty patients.
Area of Science:
- Cardiovascular Medicine
- Interventional Cardiology
Background:
- Percutaneous Transluminal Coronary Angioplasty (PTCA) is now indicated for patients with acute ischemic syndromes, multivessel coronary artery disease, and impaired left ventricular function.
- High-risk PTCA necessitates advanced techniques to mitigate procedural risks.
Purpose of the Study:
- To review and categorize the various coronary and systemic circulatory support techniques used as adjuncts to high-risk PTCA.
- To evaluate the potential of these support devices in improving angioplasty safety and expanding patient candidacy for revascularization.
Main Methods:
- Review of local coronary support techniques: perfusion balloon catheter, coronary stent, directional coronary atherectomy, laser balloon angioplasty, perfluorocarbon coronary perfusion, coronary sinus retroperfusion, and distal coronary hemoperfusion.
- Review of systemic circulatory support techniques: intraaortic balloon counterpulsation, cardiopulmonary support, hemopump, and left heart partial bypass.
Main Results:
- A range of local coronary and systemic circulatory support devices have been developed to minimize risks associated with high-risk PTCA.
- These support strategies aim to stabilize patients during complex angioplasty procedures.
Conclusions:
- Despite potential complications, circulatory support devices may improve the safety of coronary angioplasty.
- These adjuncts can enable PTCA in patients previously considered unsuitable for revascularization.
Abstract:
PTCA is now applied to patients with unstable acute ischemic syndromes, severe multivessel coronary artery disease, and impaired left ventricular function. To minimize the risk during angioplasty, several coronary and systemic circulation support approaches have been developed as adjuncts to high-risk angioplasty. Local coronary support techniques include the perfusion balloon catheter, the coronary stent, directional coronary atherectomy, laser balloon angioplasty, perfluorocarbon coronary perfusion, coronary sinus retroperfusion, and distal coronary hemoperfusion. Systemic circulatory support includes intraaortic balloon counterpulsation, cardiopulmonary support, the hemopump, and left heart partial bypass. These support devices, while associated with significant complications, may ultimately improve the safety of coronary angioplasty and allow its application to those who would otherwise not be candidates for revascularization.
More Related Videos
14:35Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs
Published on: April 17, 2021
06:10Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Published on: June 12, 2021
Related Concept Videos
Coronary Artery Disease V: Interprofessional Care
Acute Coronary Syndrome IV: Interprofessional Care
Acute Coronary Syndrome V: Nursing Management
Angina IV: Management
Peripheral Artery Disease III: Interprofessional Care
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care